CRISPR/Cas9 technology generated a C to T mutation in exon 14 which substitutes CGA encoding arginine to TGA, a stop codon that predicts termination of translation at amino acid 701 (p.R701*). This mutation has been identified in a family with focal segmental glomerulosclerosis. (J:302901)